Peer Review History
| Original SubmissionJune 25, 2020 |
|---|
|
PONE-D-20-19647 Transgender fathering: children’s psychological and family outcomes PLOS ONE Dear Dr. Condat, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process including those which are raised by the second reviewer in the text itself (see attachments uploaded by reviewer 2 Please submit your revised manuscript by Oct 05 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Michel Botbol, M.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 3. Thank you for stating the following in the Financial Disclosure section: 'AC has received funding for this project from the Pfizer Foundation and the Centre d’Activités et de Recherche en Psychiatrie Infanto-Juvénile (CARPIJ). The sponsor did not intervene in the study design and did not participate in recruitment, analysis of the data or writing of the manuscript.' We note that you received funding from a commercial source: Pfizer a. Please provide an amended Competing Interests Statement that explicitly states this commercial funder, along with any other relevant declarations relating to employment, consultancy, patents, products in development, marketed products, etc. Within this Competing Interests Statement, please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. b. Please include your amended Competing Interests Statement within your cover letter. We will change the online submission form on your behalf. Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests 4. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. 5. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables should remain as separate "supporting information" files. 6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information 7. Your ethics statement must appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please also ensure that your ethics statement is included in your manuscript, as the ethics section of your online submission will not be published alongside your manuscript. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for the opportunity to review this paper. The authors compare a sample of trans parent families (trans men and cis women with children conceived through donor insemination) with groups of donor insemination and unassisted conception families (both heterosexual-couple parent groups) on child adjustment and family process outcome measures. Very little empirical evidence exists on outcomes for children with trans parents. Trans parent families are growing in visibility and number and empirical data on trans parent families is much needed. In particular, studies using validated assessments of child adjustment (as used here) can make an important contribution, and I am not aware of any other studies with a French sample. I have several comments about the paper that may be of use to the authors. General comments: 1. In order for the reader to be able to interpret the findings more accurately, more information is needed in the methods section about the measures used, e.g. what is the possible range of scores for each measure, and what was the scale reliability for each measure? How was the FMSS scored (is this a frequency count?) and what do higher scores indicate? 2. For clearer interpretation of the results it would be helpful to see all test statistics and effect sizes included throughout the results section (not just the p-values). There are several places where the authors say ‘very few’ or ‘most’ participants and it would be helpful here to have the Ns and %s included of how many children were in each category (lines 429, 441, 454). 3. I have concerns about the scientific rigour of the family drawing task. It’s not a measure of family environment that I’m particularly familiar with but as far as I’m aware it does not seem to have valid or reliable psychometric properties or to be associated with other child outcomes. I do understand that the measure may be read differently by different audiences and the authors suggest that it may be more recognised by clinicians, but my concern is that its inclusion may detract from the important findings elsewhere in the paper (i.e. those measured using more widely recognised and validated measures like the CBCL). The journal editors’ input would be useful here. 4. There are a several places where I would recommend slight changes to language to be more inclusive, for example the phrase ‘a transgender’ is used a couple of times. I would also suggest using ‘transgender fatherhood’ or ‘trans fatherhood’ rather than ‘the trans factor’. There are also some phrases which could be more idiomatic so I would suggest having the text read by a native English speaker before publication to aid clarity. 5. In a couple of places more context would be useful for readers who are not familiar with trans parent research or assisted reproduction research, e.g. the phrase ‘crossover IVF’ (line 110) may need to be explained. Also in line 121 it may be useful to explain why these estimates are unreliable/low (i.e. that not all trans people will undergo surgical transition). 6. I have an ethical concern about data availability and would recommend considering not making the data available. I am concerned that because the trans parent population is small, even if data are anonymised, participants may still be identifiable. For example, the dataset contains families with three and four children (which is fairly uncommon) – if a dataset also included information about family structure and demographic details the families may be identifiable if this information is put together. Specific comments 1. line 33 ‘limited’ may be better than ‘paucity of’ 2. Could the abstract include the information that this is a French sample? 3. In the introduction, could a little information be included to explain the social context for trans people in France (e.g. how much societal support/opposition is there?) 4. I’m not sure that paragraph three of the introduction (beginning line 126) is necessary. Keeping the article focused on children’s outcomes would make the introduction more streamlined. 5. In introducing hypothesis (i) and (ii) it would make sense to say ‘based on the findings from the first phase of the study’ to explain the hypotheses. The authors do explain this in other places in the article but including the information here would help with understanding these hypotheses. Could the rationale for hypotheses (iii) and (iv) be included? 6. Lines 423-424 – the findings from these three measures seem to be the most important in the paper. Can the finding for each measure be presented separately with the test statistic and p-value included in the text? 7. Line 435 – does ‘friendly environment’ mean friendship groups? 8. line 447 – what direction were the differences in? 9. lines 488 and 526 – findings are reported here that I think should also be in the results section 10. lines 519-521 – I think that these studies include parent-report data but not child-report data. Zadeh et al., 2019 might be a useful reference for child-report data. 11. When discussing the CBCL scores in the discussion, could the authors say what the rates of psychopathology are among the (child) general population in France so that the findings can be interpreted with some context? 12. When discussing the expressed emotion scores it would be useful to know why this is an important construct in family psychology (i.e. what outcomes is it associated with?). If trans parents have higher rates of expressed emotion, does this matter for children’s outcomes? Reviewer #2: Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) (Limit 200 to 20000 Characters) Thank you for this important contribution to transgender care and specifically reproductive care for transgender individuals Please find attached a marked up copy of the manuscript ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Jen Hastings, MD [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Transgender fathering: children’s psychological and family outcomes PONE-D-20-19647R1 Dear Dr Condat , We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Michel Botbol, M.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-19647R1 Transgender fathering: children’s psychological and family outcomes Dear Dr. Condat: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Pr Michel Botbol Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .